Article · Volume 1, Issue 3 · pp. 264–269
A New RP-HPLC Method for Simultaneous Estimation of Nebivolol Hydrochloride and Hydrochlorthiazide in Dosage Forms
Gupta Y1, Shrivastava A2, Duggal D3, Patel A4, Agrawal S5
- 1ADL Department, Wokhardt Ltd, Aurangabad, Maharashtra, INDIA.
- 2Department of Pharmaceutical Analysis, INDIA.
- 3Department of Pharmaceutics, B. R. Nahata College of Pharmacy, Mandsaur, INDIA.
- 4Zydus Research Center, Ahmedabad, Gujrat, INDIA.
- 5Department of Q.A, Lachoo College of Science and Technology, Shastri Nagar, Jodhpur, Rajasthan, INDIA.
Abstract
A new RP-HPLC method has been developed for the simultaneous estimation of nebivolol hydrochloride and hydrochlorothiazide in pharmaceutical dosage forms, using ultra violet (UV) detector. Elution was carried out using a mobile phase consisting of acetonitrile and potassium dihydrogen phosphate buffer (pH 3.2 ± 0.1) in the ratio of 50:50 v/v and ß ow rate was set on 1.2 ml/min at 282 nm. The retention time for hydrochlorothiazide and nebivolol hydrochloride was found 3.57 and 6.66 mins, respectively. The method was found to be linear in the range of 832 μg/ml and 2080 μg/ml for nebivolol hydrochloride and hydrochlorothiazide, respectively. In the linearity study, regression equation and coefÞ cient of correlation for nebivolol hydrochloride and hydrochlorothiazide were found to be: y = 284761x + 215452, r = 0.9995; and y = 698395+105272, r = 0.9998, respectively.
Keywords: HPLC; Hydrochlorthiazide; method validation; nebivolol hydrochloride
The full text of this article is available as a PDF. Open the PDF.
